GPC Biotech AG
Officials from GPC Biotech AG detail the latest developments
Published in Physician Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at GPC Biotech AG.
Report 1: GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; Nasdaq: GPCB) announced that the Company has been informed by the U.S. Food and Drug Administration (FDA) that the New Drug Application (NDA) for satraplatin for patients with hormone-refractory prostate cancer (HRPC) whose prior chemotherapy has failed will be reviewed by the Oncologic Drugs Advisory Committee (ODAC) on July 24, 2007. Advisory committees provide the FDA with independent advice from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2007-08-15)
More Articles from Physician Law Weekly
- 7-Eleven, Inc.
Icing on the Donut! - Abbey Spanier Rodd & Abrams, Llp
Abbey Spanier Rodd & Abrams, LLP Announces Class Action Securities Fraud Suit on Behalf of Health Management Associates, Inc. Investors - Abraxis BioScience, Inc.
Abraxis BioScience Acquires Manufacturing Facility from Watson - Accellion, Inc.
Wyckoff Heights Medical Center Chooses Accellion to Safeguard Patient Data - Aging
National Conference on Medical, Legal and Ethical Issues of Eldercare - Air Methods Corporation
Air Methods Products Division Awarded EC145 Completion Contract for Geisinger Life Flight - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
